Philips, a leading health technology company, significantly increased production of its care tools, including vital signs monitors, portable ventilators, and medical consumables, to combat the COVID-19 pandemic. These tools are crucial for diagnosing and treating patients with respiratory conditions.
Philips’ commitment extends beyond ventilators. The company also ramped up production of diagnostic imaging systems like CT scanners, mobile X-ray units, and ultrasound machines. These tools enable healthcare professionals to accurately diagnose and assess the severity of respiratory illnesses. Furthermore, Philips’ telehealth solutions, such as the eICU program, allow for centralized patient monitoring and management in intensive care units, connecting caregivers with patients both in the hospital and at home.
To meet the global demand, Philips doubled its ventilator production within eight weeks of the pandemic’s onset and quadrupled it by the third quarter of 2020. This rapid scale-up was made possible by leveraging a global network of suppliers and manufacturing facilities in North America, Europe, and Asia. Philips actively collaborated with its supply chain to ensure a consistent flow of necessary materials and components.
In response to a joint call to action by the International Chamber of Commerce (ICC) and the World Health Organization (WHO), Philips urged governments to facilitate access to essential materials. The company advocated for the removal of trade barriers like export controls and tariffs and requested logistical support and exemptions from lockdown measures for crucial suppliers.
Philips prioritized equitable distribution of its critical care equipment, focusing on communities and countries with the greatest need. The company advocated for a fair and ethical allocation system based on data-driven risk assessments of each region’s COVID-19 situation. This ensured that life-saving Philips Care Tools reached those who needed them most.
Philips ventilator
